Dr. Michael Salgaller is a distinguished professional with extensive experience in biotechnology, scientific research, and technology transfer. He currently leads the Invention Development and Marketing Unit (IDMU) within the National Cancer Institute's Technology Transfer Center.
Professional Background
Career Highlights:
Senior Staff Scientist at the National Cancer Institute from 1992-1996
Vice President at Northwest Biotherapeutics, where he managed cancer vaccine clinical trials
Vice President at The Conafay Group, a healthcare-focused government affairs firm
President of Biologics Consulting Group
Investment team member at Toucan Capital, an early-stage venture capital firm
Academic and Professional Achievements
Received his PhD in Pathology from The Ohio State University
Author of "Biotechnology Entrepreneurship"
Serves on the Life Sciences Advisory Board of the Maryland Technology Council
Has authored over 100 articles, presentations, and book chapters
Teaches entrepreneurship at NIH
Current Role
Dr. Salgaller currently works at the National Cancer Institute, where he supports technology development and commercialization by fostering licensing and collaborative activities between stakeholders. He leverages over 20 years of business, scientific, and investment experience in various life science sectors.
Additional Involvement
Board member of Canines-N-Kids Foundation, supporting cooperation between pediatric and veterinary oncology researchers
Reviewer for Washington DC ArchAngels and the Cooperative Angel Alumni Group
Photographer: Michael de la Force, LIKE Magazine, 1.13.25
(Michael de la Force, LIKE® Magazine, 1.14.2025)
Source post: https://facebook.com/674873899/posts/pfbid02KwJ5fYS6A8YHPJkw4g2GwgyqMpgf3RehfLz1BHXcm9eR4THQ6WesaUfuRpRAjmAul/